<p>亨特·帕金斯資本管理公司在第三季度購買了 Align Technology, Inc.（納斯達克代碼：ALGN - 免費報告）的新股份，根據該公司最近向證券交易委員會的披露。該基金購買了 9,075 股醫療設備提供商的股票，價值約為 1,136,000 美元。</p>
<p>獲取 <strong>Align Technology</strong> 警報：</p>
<ul>
<li>為什麼這三隻科技股可能是你忽視的最佳機會</li>
</ul>
<p>其他幾家大型投資者最近也調整了他們在 ALGN 的持股。捷克國家銀行在第二季度將其在 Align Technology 的持股增加了 3.3%。捷克國家銀行現在擁有 16,654 股醫療設備提供商的股票，價值 3,153,000 美元，此前在上個季度又購買了 537 股。QRG Capital Management Inc.在第二季度購買了 Align Technology 的新股份，價值約為 306,000 美元。Envestnet Portfolio Solutions Inc.在第二季度將其在 Align Technology 的持股增加了 4.5%。Envestnet Portfolio Solutions Inc.現在擁有 2,372 股醫療設備提供商的股票，價值 449,000 美元，此前在上個季度又購買了 102 股。Navera Investment Management Ltd.在第二季度將其在 Align Technology 的持股增加了 3.0%。Navera Investment Management Ltd.現在擁有 787,559 股醫療設備提供商的股票，價值 149,126,000 美元，此前在此期間又購買了 23,080 股。最後，富蘭克林資源公司在第二季度將其在 Align Technology 的股份增加了 115.6%。富蘭克林資源公司現在擁有 17,432 股醫療設備提供商的股票，價值 3,300,000 美元，此前在上個季度又購買了 9,345 股。目前，88.43% 的股票由機構投資者和對沖基金持有。</p>
<h2>分析師設定新目標價</h2>
<p>ALGN 已成為幾份研究報告的主題。富國銀行將 Align Technology 的股票目標價從 199.00 美元下調至 181.00 美元，並在 10 月 30 日的研究報告中對該股票給予了 “增持” 評級。派珀·桑德勒重申了 “增持” 評級，並在 10 月 30 日的研究報告中對 Align Technology 的股票設定了 200.00 美元的目標價（高於 190.00 美元）。Needham &amp; Company LLC 在 10 月 30 日的研究報告中重申了 Align Technology 的 “持有” 評級。Evercore ISI 在 11 月 25 日的研究報告中將 Align Technology 的目標價從 220.00 美元下調至 170.00 美元，並對該公司設定了 “跑贏大盤” 的評級。最後，巴克萊在 12 月 8 日的研究報告中開始覆蓋 Align Technology 的股票。他們對該公司給予了 “等權重” 評級，並設定了 170.00 美元的目標價。一位分析師對該股票給予了強烈買入評級，六位分析師給予了買入評級，八位分析師給予了持有評級，一位分析師對該公司的股票給予了賣出評級。根據 MarketBeat.com 的數據，Align Technology 的平均評級為 “持有”，平均目標價為 172.18 美元。</p>
<ul>
<li>買入抄底？這些盈利失誤提供長期上漲潛力</li>
</ul>
<p><strong>閲讀我們關於 ALGN 的最新研究報告</strong></p>
<h2>Align Technology 價格表現</h2>
<p>納斯達克 ALGN 在週四開盤價為 156.45 美元。該公司的市值為 112.2 億美元，市盈率為 30.32，PEG 比率為 1.91，貝塔值為 1.86。Align Technology, Inc.的 12 個月低點為 122.00 美元，12 個月高點為 237.23 美元。該公司的 50 日簡單移動平均線為 145.16 美元，200 日簡單移動平均線為 153.75 美元。</p>
<ul>
<li>MarketBeat 週迴顧：12/25 - 12/29</li>
</ul>
<p>Align Technology（納斯達克：ALGN - 獲取免費報告）最近在 10 月 29 日宣佈了其季度財報。該醫療設備提供商報告季度每股收益為 2.61 美元，超出分析師一致預期的 2.38 美元，超出 0.23 美元。該公司在本季度的收入為 9.9569 億美元，而一致預期為 9.8075 億美元。Align Technology 的股本回報率為 13.96%，淨利潤率為 9.50%。該公司的季度收入較去年同期增長了 1.8%。在去年同期，該公司每股收益為 2.35 美元。分析師預計 Align Technology, Inc.在本年度的每股收益將達到 7.98 美元。</p>
<h2>關於 Align Technology</h2>
<p>（免費報告）</p>
<p>Align Technology, Inc.（納斯達克：ALGN）通過開發 Invisalign 系統，開創了正畸領域數字技術的使用，該系統是一系列透明、可拆卸的矯正器，提供了傳統金屬牙套的替代方案。自 1997 年由 Zia Chishti 和 Kelsey Wirth 創立以來，總部位於亞利桑那州坦佩的公司已將其關注點擴展到包括口腔內掃描儀、牙科實驗室的 CAD/CAM 軟件和全面的數字牙科解決方案。</p>
<p>該公司的標誌性 Invisalign 系統利用 3D 成像和計算機輔助設計（CAD）創建定製的矯正器，逐步重新定位牙齒，提高患者的舒適度和治療的可預測性。</p>
<h2>另見</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Align Technology</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者警報：微小的 “3 美元人工智能奇蹟股票” 即將爆發</li>
<li>是否可以從資本利得税中扣除任何費用？</li>
<li>巴菲特、蓋茨和貝索斯悄然拋售股票——原因在這裏</li>
<li>忘記人工智能，這將是下一個重大科技突破</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg"/></p>
<p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Align Technology 嗎？</h2>
<p>在你考慮 Align Technology 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而愛齊科技並不在名單上。</p>
<p>雖然愛齊科技目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

愛齊科技

<p>Hunter Perkins Capital Management LLC 在第三季度收購了 9,075 股愛齊科技（Align Technology, Inc.），價值約為 1,136,000 美元。愛齊科技是一家醫療設備供應商，報告的季度每股收益（EPS）為 2.61 美元，超出預期。該公司的股票平均評級為 “持有”，目標價格為 172.18 美元。愛齊科技的市值為 112.2 億美元，市盈率為 30.32。機構投資者持有該股票的 88.43%</p>

<p>Hunter Perkins Capital Management LLC purchased a new position in shares of Align Technology, Inc. (NASDAQ:ALGN - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 9,075 shares of the medical equipment provider's stock, valued at approximately $1,136,000.</p>
<div class="lb-trans"><p>亨特·帕金斯資本管理公司在第三季度購買了 Align Technology, Inc.（納斯達克代碼：ALGN - 免費報告）的新股份，根據該公司最近向證券交易委員會的披露。該基金購買了 9,075 股醫療設備提供商的股票，價值約為 1,136,000 美元。</p>
</div><p>Get <strong>Align Technology</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Align Technology</strong> 警報：</p>
</div><ul>
<li>Why These 3 Tech Stocks Could Be the Best Opportunities You're Overlooking</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼這三隻科技股可能是你忽視的最佳機會</li>
</ul>
</div><p>Several other large investors also recently modified their holdings of ALGN. Czech National Bank raised its holdings in Align Technology by 3.3% in the second quarter. Czech National Bank now owns 16,654 shares of the medical equipment provider's stock valued at $3,153,000 after acquiring an additional 537 shares in the last quarter. QRG Capital Management Inc. bought a new position in Align Technology during the 2nd quarter worth approximately $306,000. Envestnet Portfolio Solutions Inc. raised its position in shares of Align Technology by 4.5% during the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 2,372 shares of the medical equipment provider's stock valued at $449,000 after acquiring an additional 102 shares in the last quarter. Navera Investment Management Ltd. boosted its holdings in Align Technology by 3.0% in the second quarter. Navera Investment Management Ltd. now owns 787,559 shares of the medical equipment provider's stock worth $149,126,000 after purchasing an additional 23,080 shares during the period. Finally, Franklin Resources Inc. increased its stake in Align Technology by 115.6% during the second quarter. Franklin Resources Inc. now owns 17,432 shares of the medical equipment provider's stock valued at $3,300,000 after purchasing an additional 9,345 shares during the last quarter. 88.43% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他幾家大型投資者最近也調整了他們在 ALGN 的持股。捷克國家銀行在第二季度將其在 Align Technology 的持股增加了 3.3%。捷克國家銀行現在擁有 16,654 股醫療設備提供商的股票，價值 3,153,000 美元，此前在上個季度又購買了 537 股。QRG Capital Management Inc.在第二季度購買了 Align Technology 的新股份，價值約為 306,000 美元。Envestnet Portfolio Solutions Inc.在第二季度將其在 Align Technology 的持股增加了 4.5%。Envestnet Portfolio Solutions Inc.現在擁有 2,372 股醫療設備提供商的股票，價值 449,000 美元，此前在上個季度又購買了 102 股。Navera Investment Management Ltd.在第二季度將其在 Align Technology 的持股增加了 3.0%。Navera Investment Management Ltd.現在擁有 787,559 股醫療設備提供商的股票，價值 149,126,000 美元，此前在此期間又購買了 23,080 股。最後，富蘭克林資源公司在第二季度將其在 Align Technology 的股份增加了 115.6%。富蘭克林資源公司現在擁有 17,432 股醫療設備提供商的股票，價值 3,300,000 美元，此前在上個季度又購買了 9,345 股。目前，88.43% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Analysts Set New Price Targets</h2>
<div class="lb-trans"><h2>分析師設定新目標價</h2>
</div><p>ALGN has been the topic of several research reports. Wells Fargo &amp; Company dropped their price objective on shares of Align Technology from $199.00 to $181.00 and set an &#34;overweight&#34; rating on the stock in a research note on Thursday, October 30th. Piper Sandler reiterated an &#34;overweight&#34; rating and issued a $200.00 target price (up from $190.00) on shares of Align Technology in a research note on Thursday, October 30th. Needham &amp; Company LLC restated a &#34;hold&#34; rating on shares of Align Technology in a research report on Thursday, October 30th. Evercore ISI reduced their target price on shares of Align Technology from $220.00 to $170.00 and set an &#34;outperform&#34; rating for the company in a research note on Tuesday, November 25th. Finally, Barclays began coverage on shares of Align Technology in a research report on Monday, December 8th. They issued an &#34;equal weight&#34; rating and a $170.00 target price for the company. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Align Technology has an average rating of &#34;Hold&#34; and an average price target of $172.18.</p>
<div class="lb-trans"><p>ALGN 已成為幾份研究報告的主題。富國銀行將 Align Technology 的股票目標價從 199.00 美元下調至 181.00 美元，並在 10 月 30 日的研究報告中對該股票給予了 “增持” 評級。派珀·桑德勒重申了 “增持” 評級，並在 10 月 30 日的研究報告中對 Align Technology 的股票設定了 200.00 美元的目標價（高於 190.00 美元）。Needham &amp; Company LLC 在 10 月 30 日的研究報告中重申了 Align Technology 的 “持有” 評級。Evercore ISI 在 11 月 25 日的研究報告中將 Align Technology 的目標價從 220.00 美元下調至 170.00 美元，並對該公司設定了 “跑贏大盤” 的評級。最後，巴克萊在 12 月 8 日的研究報告中開始覆蓋 Align Technology 的股票。他們對該公司給予了 “等權重” 評級，並設定了 170.00 美元的目標價。一位分析師對該股票給予了強烈買入評級，六位分析師給予了買入評級，八位分析師給予了持有評級，一位分析師對該公司的股票給予了賣出評級。根據 MarketBeat.com 的數據，Align Technology 的平均評級為 “持有”，平均目標價為 172.18 美元。</p>
</div><ul>
<li>Buy the Dip? These Earnings Misses Offer Long-Term Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>買入抄底？這些盈利失誤提供長期上漲潛力</li>
</ul>
</div><p><strong>Read Our Latest Research Report on ALGN</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 ALGN 的最新研究報告</strong></p>
</div><h2>Align Technology Price Performance</h2>
<div class="lb-trans"><h2>Align Technology 價格表現</h2>
</div><p>NASDAQ ALGN opened at $156.45 on Thursday. The company has a market capitalization of $11.22 billion, a P/E ratio of 30.32, a PEG ratio of 1.91 and a beta of 1.86. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $237.23. The company's 50 day simple moving average is $145.16 and its 200 day simple moving average is $153.75.</p>
<div class="lb-trans"><p>納斯達克 ALGN 在週四開盤價為 156.45 美元。該公司的市值為 112.2 億美元，市盈率為 30.32，PEG 比率為 1.91，貝塔值為 1.86。Align Technology, Inc.的 12 個月低點為 122.00 美元，12 個月高點為 237.23 美元。該公司的 50 日簡單移動平均線為 145.16 美元，200 日簡單移動平均線為 153.75 美元。</p>
</div><ul>
<li>MarketBeat Week in Review: 12/25 - 12/29</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧：12/25 - 12/29</li>
</ul>
</div><p>Align Technology (NASDAQ:ALGN - Get Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The medical equipment provider reported $2.61 EPS for the quarter, beating analysts' consensus estimates of $2.38 by $0.23. The company had revenue of $995.69 million during the quarter, compared to the consensus estimate of $980.75 million. Align Technology had a return on equity of 13.96% and a net margin of 9.50%.The company's quarterly revenue was up 1.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.35 EPS. On average, analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current year.</p>
<div class="lb-trans"><p>Align Technology（納斯達克：ALGN - 獲取免費報告）最近在 10 月 29 日宣佈了其季度財報。該醫療設備提供商報告季度每股收益為 2.61 美元，超出分析師一致預期的 2.38 美元，超出 0.23 美元。該公司在本季度的收入為 9.9569 億美元，而一致預期為 9.8075 億美元。Align Technology 的股本回報率為 13.96%，淨利潤率為 9.50%。該公司的季度收入較去年同期增長了 1.8%。在去年同期，該公司每股收益為 2.35 美元。分析師預計 Align Technology, Inc.在本年度的每股收益將達到 7.98 美元。</p>
</div><h2>About Align Technology</h2>
<div class="lb-trans"><h2>關於 Align Technology</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Align Technology, Inc NASDAQ: ALGN pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.</p>
<div class="lb-trans"><p>Align Technology, Inc.（納斯達克：ALGN）通過開發 Invisalign 系統，開創了正畸領域數字技術的使用，該系統是一系列透明、可拆卸的矯正器，提供了傳統金屬牙套的替代方案。自 1997 年由 Zia Chishti 和 Kelsey Wirth 創立以來，總部位於亞利桑那州坦佩的公司已將其關注點擴展到包括口腔內掃描儀、牙科實驗室的 CAD/CAM 軟件和全面的數字牙科解決方案。</p>
</div><p>The company's signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.</p>
<div class="lb-trans"><p>該公司的標誌性 Invisalign 系統利用 3D 成像和計算機輔助設計（CAD）創建定製的矯正器，逐步重新定位牙齒，提高患者的舒適度和治療的可預測性。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另見</h2>
</div><ul>
<li>Five stocks we like better than Align Technology</li>
<li>Do not delete, read immediately</li>
<li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li>
<li>Can Any Expenses Be Deducted From Capital Gains Tax?</li>
<li>Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why</li>
<li>Forget AI, This Will Be the Next Big Tech Breakthrough</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Align Technology</li>
<li>請勿刪除，立即閲讀</li>
<li>投資者警報：微小的 “3 美元人工智能奇蹟股票” 即將爆發</li>
<li>是否可以從資本利得税中扣除任何費用？</li>
<li>巴菲特、蓋茨和貝索斯悄然拋售股票——原因在這裏</li>
<li>忘記人工智能，這將是下一個重大科技突破</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxHTg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NASDAQ&amp;Symbol=ALGN"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞警報由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Align Technology Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Align Technology 嗎？</h2>
</div><p>Before you consider Align Technology, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Align Technology 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已經識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前……而愛齊科技並不在名單上。</p>
</div><p>While Align Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然愛齊科技目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Hunter Perkins Capital Management LLC 在愛齊科技公司（Align Technology, Inc.）$ALGN 中建立了頭寸